Annual report pursuant to Section 13 and 15(d)

Schedule II - Valuation and Qualifying Accounts

v3.22.4
Schedule II - Valuation and Qualifying Accounts
 12 Months Ended
Dec. 31, 2022
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II - Valuation And Qualifying Accounts
USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES
SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS
(in thousands)
Description Balance at beginning of period Charged to costs and expenses Deductions Balance at end of period
December 31, 2022
Allowance for sales returns $ 547  $ 6,562  $ 6,537  $ 572 
Allowance for doubtful accounts $ 504  $ 6  $ 147  $ 363 
Valuation allowance - deferred tax assets $ 99,958  $ 18,178  $ —  $ 118,136 
January 1, 2022
Allowance for sales returns $ 819  $ 7,213  $ 7,485  $ 547 
Allowance for doubtful accounts $ 372  $ 148  $ 16  $ 504 
Valuation allowance - deferred tax assets $ 81,401  $ 18,557  $ —  $ 99,958 
January 2, 2021
Allowance for sales returns $ 772  $ 115  $ 68  $ 819 
Allowance for doubtful accounts $ 261  $ 131  $ 20  $ 372 
Valuation allowance - deferred tax assets $ 64,285  $ 17,116  $ —  $ 81,401